rs587776601

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong

The ENST00000246515.2(SLURP1):​c.82del​(p.Cys28AlafsTer5) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000663 in 1,612,852 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β˜…β˜…).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

SLURP1
ENST00000246515.2 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 3.99
Variant links:
Genes affected
SLURP1 (HGNC:18746): (secreted LY6/PLAUR domain containing 1) The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 17 pathogenic variants in the truncated region.
PP5
Variant 8-142741898-CA-C is Pathogenic according to our data. Variant chr8-142741898-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 4599.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-142741898-CA-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLURP1NM_020427.3 linkuse as main transcriptc.82del p.Cys28AlafsTer5 frameshift_variant 2/3 ENST00000246515.2 NP_065160.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLURP1ENST00000246515.2 linkuse as main transcriptc.82del p.Cys28AlafsTer5 frameshift_variant 2/31 NM_020427.3 ENSP00000246515 P1

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152182
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000321
AC:
8
AN:
249290
Hom.:
0
AF XY:
0.0000444
AC XY:
6
AN XY:
135190
show subpopulations
Gnomad AFR exome
AF:
0.0000620
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000533
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000664
AC:
97
AN:
1460552
Hom.:
0
Cov.:
32
AF XY:
0.0000619
AC XY:
45
AN XY:
726516
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000845
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152300
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000604
EpiCase
AF:
0.000164
EpiControl
AF:
0.000296

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 25, 2023ClinVar contains an entry for this variant (Variation ID: 4599). This premature translational stop signal has been observed in individual(s) with Mal de Meleda (PMID: 11285253, 24093092). This variant is present in population databases (rs587776601, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Cys28Alafs*5) in the SLURP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLURP1 are known to be pathogenic (PMID: 11285253, 19692209). For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingGeneDxMay 03, 2018The c.82delT pathogenic variant in the SLURP1 gene has been reported previously in the homozygous state in multiple unrelated individuals with Mal de Maleda (Fischer et al., 2001; Charfeddine et al., 2003). The c.82delT variant causes a frameshift starting with codon Cysteine 28, changes this amino acid to an Alanine residue, and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Cys28AlafsX5. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.82delT variant is observed in 10/126,090 (0.008%) alleles from individuals of non-Finnish European background in large population cohorts (Lek et al., 2016). We interpret c.82delT as a pathogenic variant. -
Acroerythrokeratoderma Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMMar 01, 2004- -
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 28, 2018The SLURP1 c.82delT (p.Cys28AlafsTer5) variant results in a frameshift and is predicted to result in premature termination of the protein. Across a selection of the literature, the p.Cys28AlafsTer5 variant has been reported in a homozygous state in a total of 15 individuals affected with mal de Meleda from eight families (Charfeddine et al. 2003; Ward et al. 2003; Bchetnia et al. 2013; Bergqvist et al. 2018). Both Charfeddine et al. (2003) and Ward et al. (2003) demonstrated that the parents of the affected individuals carried the variant in a heterozygous state. Additionally, Fischer et al. (2001) identified the p.Cys28AlafsTer5 variant in a homozygous state in an unknown number of affected individuals from 15 families. Two female obligate carriers of the p.Cys28AlafsTer5 variant were shown to have attenuated signs of skin disease (Mokni et al. 2004). Favre et al. (2007) demonstrated that the sweat of one individual with the p.Cys28AlafsTer5 variant showed an absence of SLURP1. The p.Cys28AlafsTer5 variant was absent from 200 Palestinian controls, but is reported at a frequency of 0.000079 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the evidence and potential impact of frameshift variants, the p.Cys28AlafsTer5 variant is classified as pathogenic for mal de Meleda. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587776601; hg19: chr8-143823316; API